Review

What we could do now: molecular pathology of colorectal cancer

R S Houlston

Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK

Correspondence to:
Dr Houlston r.houlston{at}icr.ac.uk

The contribution of molecular genetics to colorectal cancer has been largely restricted to relatively rare inherited tumours and to the detection of germ line mutations predisposing to these cancers. However, much is now known about the somatic events leading to colorectal cancer in general. Several studies have examined the relation between genetic features and prognosis. The purpose of this article is to review these studies and summarise the current state of this subject. Although many of the published studies are small and inconclusive, it is clear that several different pathways exist for the development of this cancer, and some molecular characteristics seem to correlate with clinicopathological features. At present, studies are confined to evaluating a small number of molecular markers; however, with the advent of methods for the rapid genetic profiling of large numbers of colorectal cancers, it will be possible to evaluate fully the clinical usefulness of a range of colorectal cancer genotypes.

Key Words: colorectal cancer • prognosis • genes

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Lips, E. H., van Eijk, R., de Graaf, E. J.R., Doornebosch, P. G., de Miranda, N. F.C.C., Oosting, J., Karsten, T., Eilers, P. H.C., Tollenaar, R. A.E.M., van Wezel, T., Morreau, H. (2008). Progression and Tumor Heterogeneity Analysis in Early Rectal Cancer. Clin. Cancer Res. 14: 772-781 [Abstract] [Full Text]  
• Provenzani, A., Fronza, R., Loreni, F., Pascale, A., Amadio, M., Quattrone, A. (2006). Global alterations in mRNA polysomal recruitment in a cell model of colorectal cancer progression to metastasis. Carcinogenesis 27: 1323-1333 [Abstract] [Full Text]  
• Lanza, G., Gafa, R., Santini, A., Maestri, I., Guerzoni, L., Cavazzini, L. (2006). Immunohistochemical Test for MLH1 and MSH2 Expression Predicts Clinical Outcome in Stage II and III Colorectal Cancer Patients. JCO 24: 2359-2367 [Abstract] [Full Text]  
• Krajewska, M., Kim, H., Kim, C., Kang, H., Welsh, K., Matsuzawa, S.-i., Tsukamoto, M., Thomas, R. G., Assa-Munt, N., Piao, Z., Suzuki, K., Perucho, M., Krajewski, S., Reed, J. C. (2005). Analysis of Apoptosis Protein Expression in Early-Stage Colorectal Cancer Suggests Opportunities for New Prognostic Biomarkers. Clin. Cancer Res. 11: 5451-5461 [Abstract] [Full Text]  
• Wang, W., Bambara, R. A. (2005). Human Bloom Protein Stimulates Flap Endonuclease 1 Activity by Resolving DNA Secondary Structure. J. Biol. Chem. 280: 5391-5399 [Abstract] [Full Text]  
• Frattini, M., Balestra, D., Suardi, S., Oggionni, M., Alberici, P., Radice, P., Costa, A., Daidone, M. G., Leo, E., Pilotti, S., Bertario, L., Pierotti, M. A. (2004). Different Genetic Features Associated with Colon and Rectal Carcinogenesis. Clin. Cancer Res. 10: 4015-4021 [Abstract] [Full Text]  
• Williams, N. S., Gaynor, R. B., Scoggin, S., Verma, U., Gokaslan, T., Simmang, C., Fleming, J., Tavana, D., Frenkel, E., Becerra, C. (2003). Identification and Validation of Genes Involved in the Pathogenesis of Colorectal Cancer Using cDNA Microarrays and RNA Interference. Clin. Cancer Res. 9: 931-946 [Abstract] [Full Text]  
• Maughan, N J, Quirke, P (2002). Pathology - a molecular prognostic approach: Advances in colorectal cancer. Br Med Bull 64: 59-74 [Abstract] [Full Text]  
• Tomlinson, I (2001). Molecular pathology of solid tumours: translating research into clinical practice. Introduction and overview. Mol. Pathol. 54: 201-202 [Full Text]